Related Experiment Video
Updated: Feb 25, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Comparative Study on Antistaphylococcal Activity of Lipopeptides in Various Culture Media
Maciej Jaśkiewicz1, Damian Neubauer2, Wojciech Kamysz3
1Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, Poland. mj@gumed.edu.pl.
Abstract:
Staphylococcus aureus bacteria are one of the leading microorganisms responsible for nosocomial infections as well as being the primary causative pathogen of skin and wound infections. Currently, the therapy of staphylococcal diseases faces many difficulties, due to a variety of mechanisms of resistance and virulence factors. Moreover, a number of infections caused by S. aureus are connected with biofilm formation that impairs effectiveness of the therapy. Short cationic lipopeptides that are designed on the basis of the structure of antimicrobial peptides are likely to provide a promising alternative to conventional antibiotics. Many research groups have proved a high antistaphylococcal potential of lipopeptides, however, the use of different protocols for determination of antimicrobial activity may be the reason for inconsistency of the results. The aim of this study was to learn how the use of various bacteriological media as well as solvents may affect activity of lipopeptides and their cyclic analogs. Obtained results showed a great impact of these variables. For example, cyclic analogs were more effective when dissolved in an aqueous solution of acetic acid and bovine serum albumin (BSA). The greater activity against planktonic cultures was found in brain-heart infusion broth (BHI) and tryptic-soy broth (TSB), while the antibiofilm activity was higher in the Mueller-Hinton medium.
Insights
Investigating lipopeptide antimicrobial activity revealed that media and solvents significantly impact effectiveness. Cyclic analogs showed enhanced activity in specific solutions, highlighting the need for standardized testing protocols for staphylococcal infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Staphylococcus aureus is a major cause of difficult-to-treat nosocomial and skin infections.
- Antibiotic resistance and biofilm formation in S. aureus complicate treatment strategies.
- Short cationic lipopeptides show promise as alternatives to conventional antibiotics.
Purpose of the Study:
- To evaluate the influence of different bacteriological media and solvents on the antimicrobial activity of lipopeptides.
- To assess the impact of these variables on the efficacy of lipopeptide cyclic analogs against S. aureus.
- To address inconsistencies in reported lipopeptide activity by examining methodological factors.
Main Methods:
- Testing lipopeptide and cyclic analog activity against Staphylococcus aureus.
- Utilizing various bacteriological media including Brain-Heart Infusion (BHI), Tryptic-Soy Broth (TSB), and Mueller-Hinton medium.
- Evaluating the effect of different solvents, including aqueous solutions with acetic acid and bovine serum albumin (BSA).
Main Results:
- Bacteriological media and solvents significantly affected lipopeptide activity.
- Cyclic lipopeptide analogs demonstrated enhanced efficacy when dissolved in aqueous acetic acid and BSA.
- Greater activity against planktonic S. aureus cultures was observed in BHI and TSB.
- Enhanced antibiofilm activity was noted in Mueller-Hinton medium.
Conclusions:
- Methodological variations in testing significantly influence the measured antimicrobial activity of lipopeptides.
- Optimizing solvent and media selection is crucial for maximizing the therapeutic potential of lipopeptides against S. aureus.
- Standardized protocols are needed to ensure consistent and reliable evaluation of lipopeptide efficacy for treating staphylococcal infections.

